News

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment was finalized on ...
Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...
Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...
Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...
Colossal Biosciences, powered by AI and amplified by Hollywood's megaphone, is proving that the story of extinction doesn't ...
The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...
This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...
Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...
Becton Dickinson’s plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and ...
Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.
Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...
A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...